Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

178.47 +0.15 (+0.08%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

23 24 Next >

Apple’s Market Maneuvers: Is AAPL Stock a Smart Buy at $193? ↗

December 28, 2023

A ban on the Apple Watch could hit AAPL stock hard as the wearable is the tech stock's second biggest money-maker

Via InvestorPlace

How A Late-Night Email To Tim Cook 10 Years Ago Possibly Triggered Masimo's Battle To Get Apple Watch Banned ↗

December 28, 2023

In 2013, a scientist named Marcelo Lamego fired off an email to Cook, pitching a vision that could propel Apple to the forefront of the medical, fitness, and wellness market, Bloomberg reported.

Via Benzinga

US Stocks Pause, Gold Rises As Dollar, Treasury Yields Fall: What's Driving Markets Wednesday? ↗

December 27, 2023

The U.S. stock market experienced a quiet day on Wednesday, with major indices showing minimal movement amid typical year-end low volume activity. The S&P 500 hovered around 4,777 points, remaining...

Via Benzinga

Apple Wins Temporary Reprieve in Watch Import Ban Over Masimo's Pulse Oximetry Patent Row ↗

December 27, 2023

On Wednesday, a U.S.

Via Benzinga

Topics Intellectual Property

Recap: Masimo Q3 Earnings ↗

November 07, 2023

Via Benzinga

Apple Pauses Watch Sale Due to Technology Dispute. What Should You Do With the Stock? ↗

December 27, 2023

Apple must halt its Apple Watch sales before Dec. 25.

Via The Motley Fool

Apple Appeals Against Smartwatch Sales Ban After White House Declines To Interfere ↗

December 26, 2023

Apple appeals against a smartwatch sales ban, filing for court review after the White House declines involvement in the U.S. International Trade Commission's imposed restriction due to a patent dispute...

Via Benzinga

Topics Intellectual Property

Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse ↗

December 24, 2023

From threats to its smartwatch operations to a significant increase in its card savings interest rate, let's delve into the Apple-centric news that unfolded this past week.

Via Benzinga

Topics Artificial Intelligence

Dow Jones Giants Apple, Microsoft Lead Five Stocks Near Buy Points ↗

December 23, 2023

Investors should keep tabs on these five stocks trading tightly.

Via Investor's Business Daily

Topics Stocks

'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute ↗

December 20, 2023

Masimo CEO Joe Kiani has expressed willingness to settle the ongoing patent dispute with Apple related to the Apple Watch Ultra 2 and Apple Watch Series 9, saying that the tech giant has not initiated...

Via Benzinga

Topics Intellectual Property

Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban? ↗

December 19, 2023

The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift...

Via Benzinga

Topics Intellectual Property

Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report ↗

December 18, 2023

Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,...

Via Benzinga

Topics Intellectual Property

Masimo Receives FDA Clearance for Stork™ Baby Monitoring System

December 18, 2023

From Masimo

Via Business Wire

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

December 11, 2023

From Masimo

Via Business Wire

Masimo to Present in Piper Sandler 35th Annual Healthcare Conference

November 27, 2023

From Masimo

Via Business Wire

Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? ↗

November 21, 2023

New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...

Via Benzinga

Topics ETFs

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

November 17, 2023

From Masimo

Via Business Wire

Masimo to Present in Jefferies London Healthcare Conference

November 09, 2023

From Masimo

Via Business Wire

Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know ↗

November 08, 2023

Via Benzinga

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

November 08, 2023

From Masimo and GE HealthCare

Via Business Wire

Robinhood, eBay, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 08, 2023

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Masimo Announces New Member of the Board of Directors

November 07, 2023

From Masimo Corporation

Via Business Wire

Masimo Reports Third Quarter 2023 Financial Results

November 07, 2023

From Masimo Corporation

Via Business Wire

Big Tech Earnings, Results From a Couple of Financial Companies, and a Look at Spotify ↗

November 05, 2023

We also chat with author Michael Lewis about Sam Bankman-Fried.

Via The Motley Fool

MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 02, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst ↗

October 27, 2023

Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI)

Via Benzinga

Masimo Surges After Winning A Potential $100 Million Battle Against Apple ↗

October 27, 2023

Federal officials say Apple violated patent laws in its Apple Watch.

Via Investor's Business Daily

Topics Intellectual Property

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge ↗

October 27, 2023

As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a...

Via Benzinga

Topics Economy Stocks

Apple's Timepiece Trouble: Patent Dispute Puts Apple Watch Imports in Jeopardy ↗

October 27, 2023

The U.S. International Trade Commission may ban the import of Apple Watches due to a patent infringement dispute with medical tech firm Masimo, pending a presidential review and potential appeals.

Via Benzinga

Topics Intellectual Property

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.